What is GlucoTrack?
GlucoTrack, Inc. is a medical device company based in Rutherford, New Jersey, dedicated to the design, development, and commercialization of novel technologies for individuals managing diabetes and pre-diabetes. The company's flagship product, GlucoTrack, is a noninvasive glucose monitoring device engineered to provide blood glucose level readings without requiring painful finger pricks. This innovation aims to significantly improve the daily lives of millions by offering a more accessible and comfortable method for health monitoring.
How much funding has GlucoTrack raised?
GlucoTrack has raised a total of $20.1M across 2 funding rounds:
Other Financing Round
$100K
Private Equity
$20M
Other Financing Round (2024): $100K, investors not publicly disclosed
Private Equity (2025): $20M led by Sixth Borough Capital Management
Key Investors in GlucoTrack
Sixth Borough Capital Management
Sixth Borough Capital Management is a multi-stage investment manager focusing on small and mid-cap equities, known for its fundamental and value-oriented approach across various sectors, including healthcare.
What's next for GlucoTrack?
The substantial enterprise-level funding and recent strategic investment position GlucoTrack to accelerate its commercialization efforts and further refine its noninvasive monitoring technology. This capital infusion is expected to fuel product development, expand market reach within the United States, and potentially support regulatory advancements. The company's focus on a critical healthcare need, combined with its technological approach, suggests a strong potential for future growth and impact in the diabetes care sector.
See full GlucoTrack company page
